Intraperitoneal Insulin Delivery: Evidence of a Physiological Route for Artificial Pancreas From Compartmental Modeling
- PMID: 35144503
- PMCID: PMC10210098
- DOI: 10.1177/19322968221076559
Intraperitoneal Insulin Delivery: Evidence of a Physiological Route for Artificial Pancreas From Compartmental Modeling
Abstract
Background: Intraperitoneal insulin delivery has proven to safely overcome a major limit of subcutaneous delivery-meal announcement-and has been able to optimize glycemic control in adults under controlled experimental conditions. In addition, intraperitoneal delivery avoids peripheral hyperinsulinemia resulting from the subcutaneous route and restores a physiological liver gradient.
Methods: Relying on a unique data set of intraperitoneal closed-loop insulin delivery obtained with a Model Predictive Controller (MPC), we develop a compartmental model of intraperitoneal insulin kinetics, which, once included in the UVa/Padova T1D simulator, will facilitate the investigation of various control strategies, for example, the simpler Proportional Integral Derivative controller versus MPC.
Results: Intraperitoneal insulin kinetics can be described with a 2-compartment model including liver and plasma.
Conclusion: Intraperitoneal insulin transit is fast enough to render irrelevant the addition of a peritoneal compartment, proving the peritoneum being a virtual-not actual-transit space for insulin delivery.
Keywords: closed-loop; insulin kinetics; intraperitoneal insulin delivery; type 1 diabetes.
Conflict of interest statement
The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: JL, AG, ER, CT, and CC have no conflict of interest to report related to this article; ED is currently an employee and shareholder of Eli Lilly and Company, the work presented in this article was performed as part of his academic appointment and is independent of his employment with Eli Lilly and Company; FJD reports equity, licensed IP, and is a member of the scientific advisory board of Mode AGC; HCZ is currently employed by Verily Diabetes. No other potential conflicts of interest relevant to this article were reported.
Figures



References
-
- Giacca A, Caumo A, Galimberti G, et al.. Peritoneal and subcutaneous absorption of insulin in type I diabetic subjects. J Clin Endocrinol Metab. 1993;77(3):738-742. - PubMed
-
- Nelson J, Stephen R, Landau S, Wilson D, Tyler F.Intraperitoneal insulin administration produces a positive portal-systemic blood insulin gradient in unanesthetized, unrestrained swine. Metabolism. 1982;31(10):969-972. - PubMed
-
- Schade D, Eaton R, Davis T, et al.. The kinetics of peritoneal insulin absorption. Metabolism. 1981;30(2):149-155. - PubMed
-
- Cobelli C, Carson E.Introduction to Modelling in Physiology and Medicine. 2nd ed.San Diego, CA: Academic Press; 2019.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical